Summary by Moomoo AI
Fosun Pharma Group Limited, Shanghai ("Board of Directors") will hold a board of directors meeting on Tuesday, August 27, 2024 to consider and approve the company and its subsidiaries' mid-year performance for the six months ended June 30, 2024 and disclose it. Fosun Pharma's executive directors include Mr. Wu Yifang, Mr. Wang Kexin, Ms. Guan Xiaohui, and Mr. Wen Deyong; non-executive directors are Mr. Chen Qiyu, Mr. Xu Xiaoliang, and Mr. Pan Donghui; independent non-executive directors include Ms. Li Ling, Mr. Tang Guiliang, Mr. Wang Quandi, and Mr. Yu Zishan. The specific content of the meeting will involve the review and approval of mid-term performance, which is an important financial information update for investors.
